J+D helps pioneering biotech launch an efficient, best-practice forecasting process
The adoption of Onco+ has helped this biotech cut the forecast development pipeline significantly and supported best practice forecasting within their team.
Announcing the launch of J+D’s expanded services, designed to support the specific forecasting needs of pharmaceutical and biotech clients.